Pharmacokinetic Study of Once-Daily Versus Twice-Daily Abacavir and Lamivudine in HIV Type-1-Infected Children Aged 3-<36 Months

Antiviral Therapy - United Kingdom
doi 10.3851/imp1532
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

International Medical Press

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy